Literature DB >> 6778456

Effect of sodium valproate on mania. The GABA-hypothesis of affective disorders.

H M Emrich, D von Zerssen, W Kissling, H J Möller, A Windorfer.   

Abstract

A possible antimanic property of the GABA-ergic anticonvulsant valproate was examined by use of a double-blind placebo-controlled ABA design in 5 acutely ill manic patients. In 4 cases a marked improvement was observed after valproate medication whereas one patient showed no response. Seven further patients with frequently recurrent episodes of a manic or maniform schizoaffective psychosis, irresponsive to lithium prophylaxis, were chronically treated with valproate in combination with low doses of lithium (one case only with valproate). Over an observation period of 1 1/2-3 years none of the patients exhibited a relapse. It is proposed that, in general, GABA-ergic anticonvulsants possess antimanic properties and that the specific antimanic effect of lithium is due to a GABA-ergic mode of action. The possible role of GABA-systems in affective disorders and in organic types of psychoses (e.g.,porphyria-psychosis, delirium tremens) is discussed on the basis of pharmacopsychiatric considerations.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6778456     DOI: 10.1007/bf00343800

Source DB:  PubMed          Journal:  Arch Psychiatr Nervenkr (1970)


  42 in total

1.  Reye-like syndrome associated with valproic acid therapy.

Authors:  N Gerber; R G Dickinson; R C Harland; R K Lynn; L D Houghton; J I Antonias; J C Schimschock
Journal:  J Pediatr       Date:  1979-07       Impact factor: 4.406

2.  Acute hepatic failure associated with the use of sodium valproate.

Authors:  F J Suchy; W F Balistreri; J J Buchino; J M Sondheimer; S R Bates; G L Kearns; J D Stull; K E Bove
Journal:  N Engl J Med       Date:  1979-04-26       Impact factor: 91.245

3.  Central effects of beta-(para-chlorophenyl)-gamma-aminobutyric acid.

Authors:  D R Curtis; C J Game; G A Johnston; R M McCulloch
Journal:  Brain Res       Date:  1974-04-26       Impact factor: 3.252

4.  Treatment of acute prophyria variegata with propranolol.

Authors:  A Atsmon; I Blum
Journal:  Lancet       Date:  1970-01-24       Impact factor: 79.321

5.  Prospects for research on schizophrenia. An hypotheses suggesting that there is a defect in the GABA system in schizophrenia.

Authors:  E Roberts
Journal:  Neurosci Res Program Bull       Date:  1972-11

6.  The measurement of change in endogenous affective disorders.

Authors:  D von Zerssen; C Cording
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1978-11-14

7.  Indication of an antipsychotic action of the opiate antagonist naloxone.

Authors:  H M Emrich; C Cording; S Pirée; A Kölling; D von Zerssen; A Herz
Journal:  Pharmakopsychiatr Neuropsychopharmakol       Date:  1977-09

8.  Baclofen (para-chlorphenyl-GABA) in schizophrenia.

Authors:  H Beckmann; M Frische; E Rüther; R Zimmer
Journal:  Pharmakopsychiatr Neuropsychopharmakol       Date:  1977-01

9.  Anti-manic and prophylactic effects of carbamazepine (Tegretol) on manic depressive psychosis. A preliminary report.

Authors:  T Okuma; A Kishimoto; K Inoue; H Matsumoto; A Ogura
Journal:  Folia Psychiatr Neurol Jpn       Date:  1973

10.  [The effect of the beta-adrenergic blocking agent propranolol in mania (author's transl)].

Authors:  W Rackensperger; W Fritsch; D Schwarz; K H Stutte; D Zerssen
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1976-10-28
View more
  32 in total

Review 1.  [Central nervous system side effects of different antibacterial substances].

Authors:  G Stoppe; E Rüther
Journal:  Infection       Date:  1991       Impact factor: 3.553

2.  Predictors of non-stabilization during the combination therapy of lithium and divalproex in rapid cycling bipolar disorder: a post-hoc analysis of two studies.

Authors:  Keming Gao; David E Kemp; Zuowei Wang; Stephen J Ganocy; Carla Conroy; Marry Beth Serrano; Martha Sajatovic; Robert L Findling; Joseph R Calabrese
Journal:  Psychopharmacol Bull       Date:  2010

Review 3.  Drug alternatives to lithium in manic-depressive disorders.

Authors:  D M Shaw
Journal:  Drugs       Date:  1988-09       Impact factor: 9.546

Review 4.  The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm.

Authors:  Konstantinos N Fountoulakis; Lakshmi Yatham; Heinz Grunze; Eduard Vieta; Allan Young; Pierre Blier; Siegfried Kasper; Hans Jurgen Moeller
Journal:  Int J Neuropsychopharmacol       Date:  2017-02-01       Impact factor: 5.176

Review 5.  Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry.

Authors:  Konstantinos N Fountoulakis; Siegfried Kasper; Ole Andreassen; Pierre Blier; Ahmed Okasha; Emanuel Severus; Marcio Versiani; Rajiv Tandon; Hans-Jürgen Möller; Eduard Vieta
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-06       Impact factor: 5.270

6.  The GABAB receptor agonist baclofen administered into the median and dorsal raphe nuclei is rewarding as shown by intracranial self-administration and conditioned place preference in rats.

Authors:  Rick Shin; Satoshi Ikemoto
Journal:  Psychopharmacology (Berl)       Date:  2010-03       Impact factor: 4.530

7.  Enhanced visual motion perception in major depressive disorder.

Authors:  Julie D Golomb; Jenika R B McDavitt; Barbara M Ruf; Jason I Chen; Aybala Saricicek; Kathleen H Maloney; Jian Hu; Marvin M Chun; Zubin Bhagwagar
Journal:  J Neurosci       Date:  2009-07-15       Impact factor: 6.167

8.  Reduced expression of GABA transporter GAT3 in helpless rats, an animal model of depression.

Authors:  M Zink; B Vollmayr; P J Gebicke-Haerter; F A Henn
Journal:  Neurochem Res       Date:  2009-03-15       Impact factor: 3.996

Review 9.  The manic syndrome: factors which may predict a patient's response to lithium, carbamazepine and valproate.

Authors:  S C Dilsaver; A C Swann; A M Shoaib; T C Bowers
Journal:  J Psychiatry Neurosci       Date:  1993-03       Impact factor: 6.186

10.  GABA and homovanillic acid in the plasma of Schizophrenic and bipolar I patients.

Authors:  Aurora Arrúe; Ricardo Dávila; Mercedes Zumárraga; Nieves Basterreche; Miguel A González-Torres; Biotza Goienetxea; Maria I Zamalloa; Juan B Anguiano; José Guimón
Journal:  Neurochem Res       Date:  2009-08-22       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.